Back to News
Market Impact: 0.3

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

AGNCDOCNDAQ
Corporate EarningsAnalyst EstimatesCompany FundamentalsMarket Technicals & FlowsInvestor Sentiment & Positioning
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks' Earnings ESP (Expected Surprise Prediction) tool is presented as a method for identifying potential earnings surprises by comparing the Most Accurate Estimate to the Zacks Consensus Estimate, leveraging recent analyst revisions. Historically, combining a Zacks Rank #3 (Hold) or better with a positive ESP has predicted positive earnings surprises 70% of the time, generating average annual returns of 28.3% over a 10-year backtest. This analytical approach suggests companies like AGNC Investment and Healthpeak, currently exhibiting positive ESPs, may post earnings beats.

Analysis

The Zacks Earnings Expected Surprise Prediction (ESP) model is highlighted as a quantitative tool for identifying companies likely to surpass earnings estimates. The methodology focuses on the most recent analyst revisions, calculating the percentage difference between the 'Most Accurate Estimate' and the 'Zacks Consensus Estimate'. According to the provided 10-year backtest, a strategy combining a positive ESP with a Zacks Rank of #3 (Hold) or better has historically predicted a positive earnings surprise 70% of the time, yielding average annual returns of 28.3%. Two specific equities are identified using this screen. AGNC Investment (AGNC), with a Zacks Rank #3 (Hold), exhibits a significant positive ESP of +5.66% ahead of its July 22, 2024 earnings report, based on a Most Accurate Estimate of $0.56 versus a consensus of $0.53. Similarly, Healthpeak (DOC), also a Rank #3 (Hold), shows a positive ESP of +1.15% for its July 25, 2024 report. Based on this quantitative framework, both AGNC and DOC are flagged as candidates poised to potentially deliver an earnings beat.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo